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Abstract
Essential oils are complex mixtures of terpenes and phenylpropanoid 
 compounds, present in multiple species of aromatic plants. They are extensively 
used in food and cosmetic industries in order to give flavor to food and drinks or 
as natural fragrances. Moreover, several compounds present in essential oils are 
important for the pharmaceutical industry due to their antioxidant, antimicrobial, 
anxiolytic or spasmolytic effects. Although many essential oils are generally recog-
nized as safe, a series of adverse reactions have been reported after their use either 
by internal or external routes. The aim of this chapter is to increase the awareness of 
healthcare professionals concerning possible safety issues of essential oils. Common 
adverse effects of essential oils like sensitization and dermatitis but also more severe 
phenomena like neurotoxicity will be presented in detail, concerning their epidemi-
ology, mechanism and clinical significance. A thorough understanding of the safety 
profile of essential oils is necessary for healthcare and food industry professionals in 
order to maximize their beneficial effects while minimizing the risk for the users.
Keywords: essential oils, terpenes, sensitization, neurological toxicity, endocrine 
disrupting potential
1. Introduction
Essential oils (EOs) are complex mixtures of aromatic terpenes (monoterpenes 
and sesquiterpenes) and other aromatic or aliphatic compounds, formed as sec-
ondary metabolites in specialized secretory tissues of aromatic plants [1]. Various 
parts of the aromatic plants (leaves, flowers, fruits, roots, bark) could be used for 
essential oil extraction by multiple techniques including steam distillation, solvent 
extraction or supercritical fluid extraction [2]. A verified botanical origin (chemi-
cal composition) and protection against contamination and oxidative degradation 
provided by adequate recipients are key factors influencing essential oils quality. 
Essential oils from peppermint, lavender, jasmine or ylang-ylang have been used 
from Antiquity in European and Asian traditional medicine for the prevention 
and treatment of several diseases but also for food flavoring. Nowadays, over 3000 
compounds have been identified in EOs and more than 300 essential oils are com-
mercially available [3] (Table 1).
Essential oils are extensively used as food flavors, as fragrances in cosmetic 
industry but also, a para-medicinal use like aromatherapy has become increasingly 
popular in the last decades (Figure 1). Moreover, due to a complex chemical compo-
sition, they are capable to interact with multiple pharmacological targets (receptors, 
ion channels or enzymes), being studied with promising results for the develop-
ment of new drug candidates. Some essential oils like peppermint oil are already 
used in clinical settings for the treatment of functional dyspepsia or irritable bowel 
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syndrome. Numerous in vitro and in vivo experiments have proved significant 
antioxidant, antimicrobial, anxiolytic, spasmolytic or anti-inflammatory effects for 
several essential oils, which could be also translated in human medicine [4, 5].
Despite their extensive use, key information concerning the safety profile of 
essential oils are not known to the general public or practitioners of aromatherapy. 
A significant proportion of the general public mistakenly believes that all essential 
oils are completely safe for human use, being hailed as “natural and risk-free medi-
cines.” Therefore, the aim of this chapter is to increase the awareness of healthcare 
and food industry professionals, but also general public, concerning possible safety 
issues of essential oils. Common adverse effects of essential oils like sensitization 
Figure 1. 
Main uses of essential oils.
No. Plant species Common name of EO
1. Boswellia carterii Frankincense
2. Cananga odorata Ylang-Ylang
3. Carum carvi Caraway
4. Cinnamomum zeylanicum Cinnamon
5. Citrus aurantium var. Amara Neroli
6. Cupressus sempervirens Cypress
7. Cymbopogon citratus Lemongrass
8. Eletaria cardamomum Cardamom
9. Foeniculum vulgare Fennel
10. Gaultheria fragrantissima Wintergreen
11. Juniperus communis Juniper
12. Melaleuca alternifolia Tea tree
13. Melaleuca viridiflora Niaouli
14. Mentha x piperita Peppermint
15. Rosmarinus officinalis Rosemary
16. Thymus vulgaris Thyme
17. Zingiber officinale Ginger
Table 1. 
A selection of commercially available essential oils and their botanical origin (in alphabetical order) [1, 2].
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and dermatitis but also more severe phenomena like neurotoxicity will be presented 
in detail, concerning their epidemiology, mechanism and clinical significance. A 
thorough understanding of the safety profile of essential oils is necessary in order to 
maximize their beneficial effects while minimizing the risk for the users.
2. Primary routes of systemic absorption of essential oils
Essential oils have a significant lipophilicity due to a high content of monoter-
penes, being capable of easily passing through several biological barriers. Thus, a 
systemic absorption of specific chemical constituents is possible after oral, cutane-
ous or pulmonary administration of essential oils with beneficial therapeutic effects 
but also with toxicological implications [6].
After an oral administration of EOs, the systemic absorption of several mol-
ecules present in their chemical composition could be significant. A study in rats 
showed that after oral administration of radio-labeled trans-anethole, over 90% 
of the substance was absorbed from the digestive tract into the bloodstream, being 
subsequently metabolized and excreted in feces and urine [7]. Recently, a study 
from 2018 showed that an immediate release formulation with geraniol orally 
administered in Sprague-Dawley rats showed an absolute bioavailability of 92%, 
thus showing an increased systemic absorption [8]. In humans, the absorption of 
1,8-cineole from the digestive tract was clearly demonstrated in a study which used 
enteric coated capsules with a mixture of three terpenoids: limonene, 1,8-cineole 
and α-pinene [9].
The contact of essential oils with the skin, frequently encountered in aromather-
apy massage, could also lead to a systemic absorption of the chemical constituents, 
depending on the contact time, size of exposed skin surface and concentration of 
the compound. Essential oils and their volatile constituents can penetrate the skin 
barrier and facilitate the absorption of other topically applied drugs by inducing a 
conformational modification of intercellular proteins in the corneal layer and by 
increasing the drug partitioning [10]. Transdermal absorption was demonstrated 
for several monoterpenes like α-pinene, camphor or limonene, other structurally 
related compounds being also capable of passing the skin barrier and generating 
systemic effects [6].
The volatility of essential oils makes them ideal for pulmonary administration, 
suitable in the treatment of respiratory diseases. Nevertheless, a fraction of the 
inhaled compounds could be rapidly absorbed at alveolar level and through airway 
mucosa, with the apparition of plasmatic concentrations and possible systemic 
effects. The pulmonary absorption was confirmed for α-pinene, camphor and men-
thol, the rate of absorption depending on the nature and concentration of inhaled 
volatile substances and local physiological factors like breathing mechanics [6].
3. General aspects of essential oil toxicity
Essential oils are easily available in pharmacies, supermarkets or online, being 
used by large segments of the general public. A recent study found that 11% 
of Australians have used essential oils in 2016, for medicinal purposes, usually 
self-prescribed [11]. Despite their popularity and extensive use, the safety profile 
of essential oils has not been fully determined to date. Chemical complexity of 
essential oils is challenging when investigating which individual components are 
responsible for certain unwanted effects. Nevertheless, some necessary steps have 
already been undertaken.
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Potential toxic effects of some essential oils and their components were tested 
on laboratory animals, usually rodents. Acute toxicity was evaluated by LD50 test 
(median lethal dose) in rats, which revealed that most essential oils have a LD50 of 
1–20 g/kg, indicating a low toxicity. In humans, some essential oils like lemon oil 
have an LD50 of above 5 g/kg. Thus, the lethal dose would be 350 g for an adult of 
70 kg, difficult to reach in normal circumstances [12, 13].
A few notable exceptions are EOs from Boldo leaf, Chenopodium, Mentha pule-
gium (pennyroyal), Satureja hortensis (savory) and Thuja who presented an LD50 
between 0.1 and 1 g/kg in rats, signaling a significant toxicity which recommends 
necessary precautions for their use [12].
Essential oils are susceptible to oxidative degradation, some of the resulting 
molecules like oxidation products of limonene being potential skin sensitizers [14]. 
Therefore, a proper storage of essential oils is necessary to conserve their effective-
ness and reduce the risk of adverse reactions. Essential oils should be stored in a 
refrigerator or in a cool, dark place in tightly sealed recipients (brown bottles).
Although most essential oils received the GRAS (generally recognized as safe) 
status, granted by Flavor and Extract Manufacturers Association (FEMA), it should 
be pointed out that they were evaluated as flavors with a very low concentration in 
the tested products. For a concentrated essential oil, certain toxic effects, local or 
systemic, could develop in specific circumstances [12].
4. Acute intoxication with essential oils
Acute intoxication (poisoning) with essential oils almost invariably results from 
an oral ingestion of large quantities of undiluted oil, usually accidental. The intoxi-
cated person may present polypnea, convulsions, nausea and vomiting or even 
death in rare cases. Tea tree oil and the oils of wintergreen, clove, cinnamon and 
eucalyptus are responsible for most cases, although acute intoxication with other 
essential oils is possible [13].
In the US, 966 intoxication cases due to tea tree oil ingestion were recorded in 2006, 
most subjects being represented by children up to 6 years old [13]. In Australia, a recent 
study identified 1387 cases of essential oil poisoning between 2014 and 2018 [15]. The 
exposures were accidental or due to a confusion between liquid cough medicines and 
essential oils. In young children, oral ingestion of 0.6–5 mL of pure eucalyptus oil is 
sufficient to cause severe symptoms, a fatal case being reported after the ingestion 
of 30 mL of the oil by an 8-month-old infant [16]. In acute intoxication, infants and 
young children are particularly at risk due to their reduced body weight combined with 
the immaturity of enzymatic systems capable of metabolizing essential oils.
Essential oil poisoning was reported also in dogs and cats treated topically with 
tea tree oil used in large doses for dermatological conditions. The animals presented 
depression, weakness, motor incoordination and tremors but they recovered after 
supportive treatment was given [17].
In order to reduce acute intoxication risk, it is recommended that essential oils 
are kept in child proof recipients, with droppers, separated from oral medication, to 
avoid confusion.
5. Dermatological toxicity of essential oils
In aromatherapy, essential oils, usually diluted in a carrier oil, are applied 
directly to the skin. The most important dermatological adverse reactions that may 
occur include irritation, sensitization and photosensitization [18, 19].
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The severity of a dermatological reaction is variable, according to factors like 
applied substance (aldehydes, phenols), used vehicle, quality/adulteration of the 
essential oil, method of application, dilution, anatomical site of exposure, integ-
rity of the skin and age of the subject. Environmental conditions could play also 
an important role. The presence of ultraviolet (UV) light is the decisive factor in 
photosensitization. Also, ambient temperature and humidity can influence general 
sensitivity, warm and humid conditions being more favorable for increased severity 
of adverse reactions [18, 19].
5.1 Skin irritation
Cutaneous irritation is the biological response of the skin to a variety of external 
stimuli that can induce skin inflammation. The main pathological mechanisms 
of irritancy include skin barrier disruption, induction of a cytokine cascade and 
involvement of the oxidative stress network [20]. Primary irritation (contact 
dermatitis) occurs rapidly the first time an essential oil is used, manifesting as a red 
wheal or burn and is more likely to occur when essential oils contain large amounts 
of compounds like phenol, carvacrol and thymol (oregano, savory or thyme), 
phenolic ethers like eugenol and anethole (clove) or aromatic aldehydes like cin-
namaldehyde (cinnamon) (Figure 2). Skin reaction is usually limited to the area 
where the essential oil is applied [21].
The plants whose essential oils are potentially irritant to the skin are listed in 
Table 2. Considering all these aspects, it is recommended that a patch test should be 
performed before using these oils.
5.2 Skin sensitization
In contrast to irritation, skin sensitization is a response of the adaptive immune 
system to certain chemical substances called sensitizers or haptens, which can 
modify skin proteins and induce a delayed T-cell-mediated allergic response [23]. 
Some of the ingredients which may trigger allergic reactions are listed in the seventh 
amendment of directive 76/768 CEE (directive 2003/15/CE) and include benzyl 
alcohol, cinnamyl alcohol, citral, eugenol, hydroxycitronellal, isoeugenol, benzyl 
salicylate, cinnamaldehyde, coumarin, geraniol, anisyl alcohol, benzyl cinnamate, 
farnesol, linalool, benzyl benzoate, citronellol, or limonene [24, 25]. Skin sensitiza-
tion occurs on first exposure to a substance, with only a slight (or absent) effect on 
the skin. Subsequent exposure to the same compound/compounds will produce a 
severe inflammatory reaction caused by T-lymphocytes.
Figure 2. 
Chemical structures of the main skin irritant compounds.
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Symptoms include a bright red rash, which may be painful to some individuals 
and sometimes a pigmentation of the skin, more frequently in Asians [21, 24]. In 
order to prevent sensitization, it is recommended to avoid known dermal sensitizers 
and avoid application of the same essential oil every day for a long period of time.
Table 3 lists some of the oils considered to be dermal sensitizers, but the sensiti-
zation process can occur for any essential oil [22, 25].
Essential oils obtained from different species of Pinus and Abies should only be 
used when the level of peroxides is kept to the lowest practical level, preferably by 
adding anti-oxidants at the time of production [19].
Skin sensitization reactions are idiosyncratic, identification of the causative 
allergen(s) and their subsequent withdrawal generally leading to a resolution of the 
problem. Some standard mixtures (fragrance mixture) can be used in a patch test 
to screen for allergic reactions in susceptible individuals, but not all the allergies can 
be predicted by this method [26, 27].
5.3 Photosensitization
Photosensitization is a reaction between a phototoxin from an essential oil that 
is applied to the skin in the presence of sunlight or ultraviolet A (UVA) light. The 
interaction with the light may be either phototoxic or photoallergic.
Photoallergy is an immune-mediated skin reaction, while phototoxicity may 
lead to photocarcinogenesis. Furanocoumarins (psoralens) appear to be primar-
ily responsible for phytophototoxic reactions in humans. Reactions can vary from 
pigmentation, blistering, to severe full-thickness burns. Furanocoumarins occur 
mainly in expressed citrus peel oils (C. bergamia, C. aurantium, C. limon, C. auran-
tifolia) although they are also found in angelica root (Angelica archangelica), rue 
(Ruta graveolens), cumin (Cuminum cyminum) parsley leaf (Petroselinum crispum), 
and marigold (Tagetes minuta) essential oils [19, 28].
The most common compounds are bergapten and psoralen (Figure 3). They are 
not found in distilled citrus peel oils [21].
Latin name (botanical family)/common name Part used in EO extraction
Cuminum cyminum (Apiaceae)/Cumin Fruits
Tagetes minuta (Asteraceae)/Marigold Leaves
Origanum vulgare (Lamiaceae)/Oregano Aerial parts
Satureja hortensis (Lamiaceae)/Summer savory Leaves
Satureja montana (Lamiaceae)/Winter savory Leaves
Thymus capitatus ct. carvacrol or thymol (Lamiaceae)/Spanish oregano Aerial parts
Thymus serpyllum (Lamiaceae)/Wild thyme Aerial parts
Thymus vulgaris ct. phenol (Lamiaceae)/Red thyme Aerial parts
Cinnamomum cassia (Lauraceae)/Chinese cinnamon Barks
Cinnamomum zeylanicum (Lauraceae)/True cinnamon Leaves, barks
Pimenta racemosa (Myrtaceae)/Bay rum tree Fruits, leaves
Syzygium aromaticum (Myrtaceae)/Clove Buds, leaves, stems
Cymbopogon citratus (Poaceae)/Citronella Aerial parts
Cymbopogon nardus (Poaceae)/Lemongrass Aerial parts
Lippia citriodora (Verbenaceae)/Lemon verbena Leaves
Table 2. 
Essential oils potentially irritant to the skin (in alphabetical order of the botanical family) [22].
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The factors influencing risk of photosensitization include the amount of essen-
tial oil applied topically and the area of exposure. It is considered there is no risk 
of photosensitization if the skin is covered to prevent exposure to UVA light for at 
least 2 h [28].
6. Neurological toxicity of essential oils
Essential oils could easily pass the blood-brain barrier, reaching the central ner-
vous system after a systemic absorption. In an experimental setting, essential oils 
from Salvia officinalis and Hyssopus officinalis evoked convulsions after intraperito-
neal administration in rats at doses of 0.5 g/kg and 0.13 g/kg, respectively [29].
In humans, essential oils from Salvia officinalis, Thuja plicata, Cedrus spp., 
Hyssopus officinalis, Eucalyptus spp., Mentha pulegium, Cinnamonum camphora and 
Anethum graveolens produced tonic-clonic convulsions, particularly in children 
and especially in those with a history of epileptic syndromes, according to several 
reports [30, 31].
Latin name (botanical family)/common name Part used in EO extraction
Cananga odorata (Annonaceae)/Ylang ylang Flowers
Inula helenium (Annonaceae)/Elecampane Flowers, leaves
Saussurea costus (Asteraceae)/Costus Roots
Commiphora erythraea (Burseraceae)/Opoponax Resin
Myroxylon pereirae (Fabaceae)/Peru balsam Resin
Liquidambar styraciflua (Hamamelidaceae)/Styrax Resin
Cinnamomum cassia (Lauraceae)/Chinese cinnamon Barks
Cinnamomum zeylanicum (Lauraceae)/True cinnamon Leaves, barks
Melissa officinalis (Lamiaceae)/Lemon balm Leaves
Backhousia citriodora (Myrtaceae)/Lemon myrtle Leaves
Melaleuca alternifolia (Myrtaceae)/Tea tree Leaves
Pimenta racemosa (Myrtaceae)/Bay rum tree Fruits, leaves
Syzygium aromaticum (Myrtaceae)/Clove Buds, leaves, stems
Pinus spp. (Pinaceae)/Turpentine Leaves
Cymbopogon nardus (Poaceae)/Lemongrass Aerial parts
Lippia citriodora (Verbenaceae)/Lemon verbena Leaves
Table 3. 
Essential oils considered to be dermal sensitizers (in alphabetical order of the botanical family) [21, 22].
Figure 3. 
Chemical structure of the most common furanocoumarins involved in photosensitization.
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The identified chemical constituents responsible for convulsions were usually 
1,8-cineole, camphor, thujone, pulegone and pinocamphone (Figure 4) [29, 30].
Molecular mechanisms of the convulsant effect of essential oils and their 
constituents were investigated in laboratory animals. According to a study, some 
essential oils resemble pentylentetrazole, a powerful convulsive agent, modify-
ing tissue gradients of Na and K and leading to increased cellular excitability 
in the brain [32]. In another experimental study, thujone one of the frequently 
incriminated pro-convulsant terpenes, suppressed GABA-induced peak currents 
in rat dorsal root ganglion neurons, with the subsequent apparition of convulsions, 
terminated by diazepam or phenobarbital [33]. On the contrary, other research 
proved that different terpenes could have an anticonvulsant effect. Menthol, 
another terpene derivative found in the chemical composition of some essential oils 
enhanced electric currents induced by low concentrations of GABA and directly 
activated GABAA receptors in laboratory animals [34].
In the context of potential neurological toxicity of essential oils, European 
Medicines Agency (EMA) reviewed the safety of suppositories containing ter-
penes used in seven European countries (France, Belgium, Portugal, Spain, Italy, 
Luxembourg and Finland) for the treatment of respiratory diseases. The report 
concluded that terpenes could induce convulsions in children less than 30 months, 
recommending they should be contraindicated in this particular segment of 
patients [35].
7. Endocrine disrupting potential of essential oils
In the last decade, there has been an accumulation of evidence suggesting a 
possible endocrine disrupting effect of some essential oils. Initially, a report sig-
naled the apparition of idiopathic male prepubertal gynecomastia in patients with 
topically applied lavender oil or tea tree oil [36]. The experimental data showed that 
both lavender oil and tea tree oil effects are produced by the activation of estrogenic 
receptors (ER), with a potency of 50% of estradiol, being attenuated in the pres-
ence of fulvestrant, a pure antagonist of ER receptors.
Recently, another study published in 2019, confirmed the mentioned data, 
showing that a continuous exposure to lavender-fragranced products induced a 
Figure 4. 
Chemical structure of terpenes with epileptogenic potential.
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premature thelarche in four patients [37]. The chemical constituents from the 
essential oils were individually tested concerning their capacity of stimulating ERα 
estrogen response element (ERE)-mediated activity. The most active compounds 
with estrogenic activity were α-terpineol, 4-terpineol and linalool. Further research 
on a more statistically significant population is needed to confirm the relevance of 
these findings [37].
8. Essential oils in pregnancy and lactation
The main concerns of the use of essential oils during pregnancy is related to 
the risk of chemical compounds crossing the placental barrier with direct effects 
on the product of conception, but also to the direct abortive effect. The use of 
essential oils during pregnancy is a controversial topic and one that is yet to be fully 
understood.
Some essential oils are abortifacients, being capable of inducing miscarriage/
abortion. Essential oils like persil oil (Petroselinum sativum) rich in apiole, pen-
nyroyal oil (Mentha pulegium) rich in pulegone, plectranthus oil (Plectranthus 
amboinicus), Spanish sage oil (Salvia lavandulifolia) or savin oil (Juniperus sabina) 
rich in sabinyl acetate should be avoided during pregnancy (Figure 5). The amounts 
required to induce an abortion may also pose toxicity risks to the mother, including 
kidney and liver damage (could be the reason of pregnancy termination in penny-
royal oil case) or even death [12, 38].
Due to their chemical properties (low molecular weight, lipophilicity), it 
is likely that certain essential oil components could cross the placental barrier, 
reaching fetal circulation. Following a possible biotransformation into polar 
molecules, they can accumulate in the fetus due to a reduced glomerular filtra-
tion rate and low content of plasma proteins capable of binding xenobiotics  
[13, 38].
Essential oils should not be used in pregnancy (or breastfeeding) if they contain 
large amounts of the following components: (E)-anethole (aniseed-Pimpinella 
anisum, star anise-Illicium verum, fennel-Foeniculum vulgare, dill-Anethum gra-
veolens), apiole (persil-Petroselinum sativum), β-eudesmol (cypress-Cupressus 
sempervirens), camphor (Spanish lavender-Lavandula stoechas), methyl salicylate 
(sweet birch-Betula lenta), pinocamphone (hyssop-Hyssopus officinalis), or thujone 
(mugworth-Arthemisia vulgaris, savin-Juniperus sabina, thuja-Thuja occidentalis) 
[12, 38].
Figure 5. 
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9. Conclusions
Essential oils have gained an increased attention in the last decades, being used 
as flavors, fragrances, medicines or in aromatherapy. Although generally considered 
as “natural and safe,” some essential oils could cause significant adverse effects 
like skin sensitization and contact dermatitis, neurological toxicity or endocrine 
dysregulations.
An increased awareness of healthcare professionals and general public concern-
ing the safety profile of essential oils is needed in order to correctly exploit their 
diverse biological effects.
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